Your
Peptide Development Partner
APC Biotech has developed NextPep,
a platform for the rapid, economical and scalable production of long and difficult
peptides. This new, recombinant method has many advantages over chemical synthesis.
The technology is available for contract production or licensing.
Subunit Vaccine Production
APC Biotech is developing SpeedVaccs,
our new platform for the manufacture of recombinant, subunit vaccines. This
platform co-displays a conformationally constrained B-cell epitope along with
a T-cell epitope for greater immune response. The method has shown great promise
in proof of concept trials in animals.
Research Reagents
We have a line of research
reagents including high quality, biologically active recombinant
proteins and sensitive ELISA tests. Many of these products are not available
anywhere else.
News
Dec 2009: APC Biotech launches their new website.
Oct 2009: APC Biotech selected for participation in the NIH Commercialization
Assistance Program.
July 2009: APC Biotech recieves a phase II SBIR grant from the NIH.
